HemeTalks: Conversations in Hematology Education is an American Society of Hematology (ASH) podcast for community hematologists, advanced practice providers, and trainees. Through engaging storytelling and case-based discussions with guests ranging from early-career professionals to leading experts, the podcast offers practical strategies that make complex hematology topics accessible and relevant at every career stage. Its mission is to support the educational needs of its audience through high-quality, clinically focused content.
HemeTalks: Conversations in Hematology Education
Claim This Podcastby American Society of Hematology
5.0(2 reviews)
39 episodes
Updated Bi-weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
15
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality16
Social0
YouTube0
Engagement32
Podcast Overview
HemeTalks: Conversations in Hematology Education is an American Society of Hematology (ASH) podcast for community hematologists, advanced practice providers, and trainees. Through engaging storytelling and case-based discussions with guests ranging from early-career professionals to leading experts, the podcast offers practical strategies that make complex hematology topics accessible and relevant at every career stage. Its mission is to support the educational needs of its audience through high-quality, clinically focused content.
Language
🇺🇲
Publishing Since
6/7/2023
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
15
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality16
Social0
YouTube0
Engagement32
6
Excellent Areas
2
Good Performance
11
Growth Opportunities
excellent
Episode Length
22 minutes
Performing excellently!
good
Show Experience
24 episodes over 2.2 years
Recommendations available
Unlock the full report to see detailed tips
poor
Publishing Consistency
Every 34 days
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for HemeTalks: Conversations in Hematology Education
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
July 16, 2026
Warm AIHA: The Patient Perspective
<p>In this episode of Heme Talks, we are joined by Mr. Sean Powell as he shares his experiences as a former patient and now patient advocate for a rare blood disorder known as warm autoimmune hemolytic anemia (wAIHA). Sean shares his story of how he was diagnosed, the initial management, drug toxicities, and subsequent investigations that he underwent. Our patient advocate episodes highlight the importance of advocacy, community, and shared understanding between patients and their healthcare providers. </p><p><strong>Key Takeaways</strong></p><p>1. wAIHA can sometimes be associated with an underlying condition. Mr. Powell’s journey illustrates how wAIHA occasionally occurs alongside other diagnoses, highlighting the value of ongoing clinical vigilance and open communication between patients and their care team. </p><p><br></p><p>2. Steroid therapy carries significant side effects that patients are often unprepared for. Mr. Powell experienced severe prednisone toxicities, including rage, insomnia, and extreme hunger, and his hemolysis was only transiently controlled. His experience highlights the need for proactive patient counseling about steroid side effects and the importance of escalating to second-line therapies like rituximab when steroids fail. </p><p><br></p><p> 3. The emotional and psychological burden of transitioning from active treatment to remission is often underestimated. Even after achieving remission, Mr. Powell faced intense anxiety, isolation, and loneliness — feelings that emerged precisely when formal support structures faded. Routine referrals to behavioral health specialists and survivorship programs should be considered a standard part of care, not an afterthought. </p><p><br>This podcast episode is supported by Johnson & Johnson.</p>
July 2, 2026
Warm Autoimmune Hemolytic Anemia: Challenges, Choices, and New Therapies
<p>In this episode of Heme Talks, we are joined by Allyson Pishko, MD, MSCE, Classical Hematologist and Assistant Professor of Medicine at the University of Pennsylvania, to discuss a rare blood disorder known as warm autoimmune hemolytic anemia (wAIHA). In this episode, Dr. Pishko shares her approach to diagnosis and management of this disorder, and how she approaches discussions about this diagnosis with her patients. Dr. Pishko also discusses promising future options for patients with wAIHA. </p><p><strong>Clinical Perls:</strong></p><ol><li>Warm autoimmune hemolytic anemia is a complex diagnosis. In addition to a careful history, key lab data to support the diagnosis can include an acute drop in hemoglobin, elevated bilirubin, elevated lactate dehydrogenase (LDH), reduced haptoglobin, an elevated reticulocyte count, and a positive Coombs’ test. Microspherocytes may also be visible on a smear. However, not all patients will present with all of these findings, and it is also important to consider the patient’s comorbid conditions when interpreting labs. </li><li>Corticosteroids remain the backbone of treatment with a slow taper over many weeks pending clinical improvement. Additional therapies include rituximab and immunosuppressive agents. </li><li>For refractory patients, additional options to consider agents including fostaminib and rilzabrutinib. Nipocalimab is currently also being reviewed by the FDA. </li></ol><p>This podcast episode is supported by Johnson & Johnson.</p>
June 18, 2026
Unfolding Amyloid: A Patient Perspective
<p>In this episode of Heme Talks, we are joined by Dr. Sai Jambunathan as she shares her experiences with the diagnosis and management of a rare blood disorder known as AL amyloidosis. As a patient herself, listeners will gain insights into the complex initial workup and what the treatment journey is like for patients with this condition. Our patient advocate episodes highlight the importance of advocacy, community, and shared understanding between patients and their healthcare providers. </p><p><strong>Key Takeaways:</strong></p><ol><li><strong>AL amyloidosis can present without classic symptoms, making early recognition challenging.</strong> Dr. Jambunathan's initial symptoms — fatigue, shortness of breath, and night sweats — were subtle and initially attributed to other causes. Clinicians should maintain a broad index of suspicion, as timely diagnosis significantly impacts prognosis. </li><li><strong>Clear, compassionate communication from the care team makes a meaningful difference for patients and families.</strong> From explaining the diagnosis in accessible language to giving family members direct reassurance, Dr. Jambunathan's experience shows how much patients value providers who take the time to communicate honestly, patiently, and with empathy. </li><li><strong>Community, advocacy, and peer support are powerful tools for patients navigating a rare disease.</strong> Dr. Jambunathan found strength through patient support groups, faith communities, and caregivers — and channeled her experience into advocacy, helping pass an AL amyloidosis awareness month in New Jersey. Organizations like the Amyloidosis Research Consortium offer valuable resources for patients and families seeking connection and information. </li></ol><p>This podcast is supported by Alexion.</p>
39 total episodes available
Recent guests on HemeTalks: Conversations in Hematology Education
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Richard Burwick
Guest
Shruti Chaturvedi
Guest
Dr Margo Rollins
Guest
experts from cellular therapy and bone marrow transplantation (BMT)
Guest
Similar Podcasts
Discover related shows you might enjoy
Blood Podcast
American Society of Hematology
Two Onc Docs
Sam and Karine
The Hematologist
The Hematologist
ASCO Daily News
American Society of Clinical Oncology (ASCO)
The Clinical Problem Solvers
The Clinical Problem Solvers
JAMA Clinical Reviews
JAMA Network
Annals On Call Podcast
American College of Physicians
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
NEJM This Week
NEJM Group
Core IM | Internal Medicine Podcast
Core IM Team
Harrison's PodClass: Internal Medicine Cases and Board Prep
AccessMedicine
Chasing Life
CNN Podcasts
The Happiness Lab with Dr. Laurie Santos
Pushkin Industries
Blood Cancer Talks
Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff
Point Me To First Class
Devon Gimbel MD
Deep-dive analytics for HemeTalks: Conversations in Hematology Education
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is HemeTalks: Conversations in Hematology Education?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.